
News
Home>News & Events>Publications>TTC>The Role of Patient-reported Outcomes and Medication Adherence Assessment in Patient-focused Drug Development for Solid Organ Transplantation
357
Related Posts
-
Applying propensity methods to the United States transplant registry for external real-world evidence control arms for 5-year survival in the BENEFIT study
-
Qualifying a novel clinical trial endpoint (iBOX) predictive of long-term kidney transplant outcomes
-
Qualifying a novel clinical trial endpoint (iBOX) predictive of long-term kidney transplant outcomes
-
Longitudinal estimated glomerular filtration rate (eGFR) modeling in long-term renal function to inform clinical trial design in kidney transplantation
-
Acute Rejection After Kidney Transplant—An Endpoint Not Predictive of Treatment Effect on Graft Survival